SUMMARY We have studied the relation between left ventricular peak systolic pressure and endsystolic volume in 12 normal subjects and 12 patients with coronary artery disease. Peak systolic pressure was measured with a cuff sphygmomanometer and left ventricular volumes were determined by radionuclide ventriculography.
Scintigraphic study of relation between left ventricular peak systolic pressure and end-systolic volume in patients with coronary artery disease and normal subjects JOHN WATKINS,* ROBERT SLUTSKY, JULIO TUBAU, JOEL KARLINER From the Division of Cardiology, University of California, San Diego, Califomia, USA SUMMARY We have studied the relation between left ventricular peak systolic pressure and endsystolic volume in 12 normal subjects and 12 patients with coronary artery disease. Peak systolic pressure was measured with a cuff sphygmomanometer and left ventricular volumes were determined by radionuclide ventriculography.
Observations were made at rest, after 1 mg atropine, and during at least three increments of an infusion of phenylephrine which raised systolic blood pressure by 45 mmHg while heart rate was held constant.
The relation between peak systolic pressure and end-systolic volume at a constant heart rate was found to be linear in all subjects. The slope of this line was steeper in normal subjects than in patients with coronary artery disease and correlated exponentially with the ejection fraction determined simultaneously. The end-systolic volume extrapolated to zero pressure (V0) was not significantly different between the two groups and correlated poorly with the ejection fraction.
The simple ratio of peak systolic pressure to end-systolic volume, at rest and after drug interventions, was of similar sensitivity to the ejection fraction in the detection of patients with left ventricular dysfunction caused by coronary artery disease. In normal subjects, however, this ratio rose after atropine whereas the ejection fraction was unchanged.
The apparent suneriority of the ratio of peak systolic pressure to end-systolic volume over the ejection fraction in the detection of the positive inotropic response to increasing heart rate, coupled with the linearity of this relation over a wide range of systolic blood pressure, suggests that the systolic pressure-volume relation will prove useful in the evaluation of cardiac drug effects in man.
None of the indices derived from the systolic pressure volume relation, however, was more sensitive than the ejection fraction derived simultaneously, in the detection of patients with left ventricular dysfunction resulting from coronary artery disease.
The relation between left ventricular pressure and finding that peak systolic pressure can be substituted volume at end-systole in experimental models has for end-systolic pressure without significantly altering been shown to be a sensitive and relatively preload-these propertiesY4-6 independent index of the prevailing inotropic Considerable interest has thus been shown in this state. -3 relation, both as a method of studying cardiac drug The utility of this relation as a putative index of effects and also as a means of detecting myocardial inotropic state in man has been enhanced by the dysfunction caused by coronary artery disease. [4] [5] [6] [7] [8] [9] [10] The simple ratio of peak systolic pressure to end- We have therefore undertaken a scintigraphic study in normal subjects and patients with coronary artery disease: (i) to confirm the linearity of the peak systolic pressure-end-systolic volume relation in man by a method that does depend on geometric assumptions about ventricular morphology at end-systole; (ii) to compare the P/V ratio, the P/V slope, and VO-all derived at a constant inotropic state-with the ejection fraction obtained simultaneously; (iii) to compare the sensitivity of these indices in the detection of impaired myocardial function resulting from coronary artery disease.
Subjects and methods
The study was 12 Left ventricular counts at end-diastole, corrected for frame time and the number of cardiac cycles processed, were divided by counts from whole blood drawn at the mid-point of each study, corrected for background activity, elapsed time, and radioactive decay.
Thus SV=EFxEDV ml and, finally, ESV was calculated as:
ESV=EDV-SV ml All ventricular volumes were reported as volume indices, that is ml/m2 body surface area. The reproducibility of this technique has been validatd in our own and other laboratories. The reproducibility over time of end-diastolic volume and ejection fraction using this method was +7 5 ml and ±3%, respectively. 1415 Inter-and intra-observer variability have both been found to be approximately 4%. 15 Individual plots were then constructed using three (n=8), four (n= 12), or five (n=4) points to define the relation between the mean value of systolic blood pressure during a five minute scintigram and the calculated end-systolic volume index, over a physiological range of blood pressure.
Data were used only if heart rates during the various steps of phenylephrine infusion were successfully maintained within six beats a minute of the initial post-atropine value. Thus, the resting (pre-atropine) data were not included in these plots. Table 2 . Blood pressure and heart rate were similar in the two groups, the major difference being a Watkins, Slutsky, Tubau, Karliner larger end-systolic volume in the patients with coronary disease (50+24 m/rM2 compared with 22+7 m/rM2 in the normals, p<0-01).
While the mean P/V ratio was significantly lower in the patients with coronary disease than the normal subjects (2-79± 1*00 mmHg/ml per m2 compared with 6*23±2*47 mmHg/ml per m2, p<0.01), it was not significantly better than the ejection fraction in the identification of individual patients with left ventricular dysfunction caused by coronary artery disease (Fig. 1) .
After atropine The response to 1 mg intravenous atropine is shown in the left hand panels of Tables 3 and 4 for normal subjects and patients with coronary artery disease, respectively. Heart rate rose by 20 to 25 beats a minute and diastolic blood pressure rose by 5 to 8 mmHg in each group. The P/V ratio was significantly increased by atropine in the normal subjects (from 6*23+2*47 to 7-28+2*7 mmHg/ml per m2, p<0-01) but did not rise significantly in the patients with coronary artery disease (from 2*79+1*00 to 3*28+1*66 mmHg/ml per m2).
By contrast, the ejection fraction showed a nonsignificant decline after atropine in both groups. In the patients with coronary disease, stroke volume fell significantly (from 50±_24 to 32± 12 mi/M2, p<0-01) but was maintained in the control group (53±13 m/rM2 at rest, 46± 18 miM/2 after atropine -NS). Fig. 2 is a plot of the relation between the P/V ratio and the ejection fraction after atropine administration. The relation is best described by the exponential equation y=0. 82xe03X, as illustrated. Note that most of the normal subjects lie on the steep part of the curve, where ejection fraction is relatively insensitive to changes in the P/V ratio. During phenylephrine rate permitted to fall by >6 beats/minute from the The maximum haemodynamic respone to the pressor post-atropine value. The P/V ratio fell in both groups effects of phenylephrine are shown in the right hand but was only significantly reduced in the normal subpanels of Tables 3 and 4 for normal subjects and jects (from 7-28+2-27 to 5-87±+1.40 mmHg/ml per patients with coronary disease, respectively. Mean m2, p<0.01). systolic blood pressure was similarly raised (42 and 39
Mean ejection fraction also fell in both groups durmmHg) in both groups, and in no subject was heart ing phenylephrine though again this was only For key to abbreviations see Table 2 .
significant in the normal subjects (from 70+9 to 64±9%, p<0*01). Thus, the P/V ratio and the ejection fraction appeared to be similarly afterloaddependent in both groups studied. 24 subjects studied. The slopes of these lines were significantly steeper in normal subjects than in the patients with coronary artery disease (3-9+0.9 mmHg/ml per m2 compared with 2 5_0-6 mmHg/ml per m2, p<0.05) though there was some overlap of individual values between the two groups (Fig. 3) . Ten of 12 normal subjects, however, but only four of 12 patients with coronary disease had a P/V slope >2-7 mmHg/ml per M2. The P/V slope correlated exponentially with the ejection fraction determined at the same heart rate (that is after atropine), as shown in Fig. 4 . Thus, as with the P/V ratio, most of the normal subjects fell on the steep part of the curve, where the ejection fraction is relatively insensitive to changes in the P/V slope.
The observed intercept of the P/V slope on the volume axis was not significantly different between the two groups (see Table 5 for individual linear regression data). VO was calculated as -bla where a is the P/V slope and b is the observed intercept on the volume axis. Mean VO was -16+10 ml/m2 in the normal subjects and -4±+25 ml/m2 in the coronary artery disease group (NS). No significant correlation was found between VO and ejection fraction overall, though there appeared to be a trend towards an inverse relation with values of less than 50% for ejection fraction (Fig.   5 ).
----CAD patients -Normal subjects n= 24 Fig. 3 Individual plots showing the linear relation between the increase in systolic blood pressure and the resultant rise in end-systolic volume.
The slope ofthese lines in the patients with coronary artery disease tends to be less steep than in normal subjects, but there is some overlap ofthe two groups.
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A ESVI (ml/rm2) Fig. 5 Plot of V0 against ejection fraction (EF) determined at slopes seen in Fig. 3 and the ejection fraction determined at the the same heart rate. Though no signj'icant correlation was found same heart rate, that is immediately after atropine.
overaUl, there was a trend towards an inverse correlation in patients whose post-atropine ejection fraction (EF) was <36%. 
Discussion
This study has confirmed the linearity of the peak systolic pressure/end-systolic volume relation in man at a constant inotropic state and over a physiological range of blood pressure. Previous studies using M-mode echocardiography16 and contrast ventriculography6 have also shown a linear relation but, unlike radionuclide ventriculography, both these methods are dependent on geometric assumptions about the shape of the left ventricle at end-systole, assumptions that may be particularly inappropriate in patients with previous myocardial infarction.
The slope of this relation has been shown in previous clinical and experimental studies to be an index of inotropic state.24 16 We found an exponential relation between the P/V slope and the ejection fraction, confirming the findings of Mehmel et al.6 Most normal subjects fell on the steep part of the curve (see Fig. 4 ) suggesting that the P/V slope might be more sensitive to changes in inotropic state than the ejection fraction, at least in such normal subjects.
Although the mean P/V slope was steeper in the normal subjects than in those with coronary disease, there was considerable overlap between the two groups, presumably because the resting contractile state of the left ventricle is not invariably depressed after myocardial infarction.
The ejection fraction is commonly used in clinical practice as a measure of the contractile state of the left ventricle, but it is also influenced by changes in heart rate, preload, and afterloading conditions. Thus, when preload is decreased or afterload increased, the ejection fraction is depressed even if the inotropic state of the left ventricle is constant. Despite this limitation, the ejection fraction is widely used to detect, quantify, and prognosticate upon left ventricular dysfunction in patients with coronary artery disease. [17] [18] [19] The P/V slope, however, being linearly afterload dependent and virtually unaffected by preload, may more accurately reflect the inotropic state of the left ventricle than the ejection fraction under circumstances where both cardiac loading conditions and inotropic state are changing. Indeed, the P/V relation is now being used to evaluate cardiovascular drug effects in man. 10 20 By contrast, the extrapolated value of end-systolic volume at zero pressure (VO) did not correlate significantly with the ejection fraction in our study, nor was it significantly different in subjects with and without left ventricular dysfunction caused by coronary artery disease. This is in contrast to the findings of Grossman et al.,4 who observed a significantly higher value for VO in patients with a depressed ejection fraction than those with a normal ejection fraction, as assessed by contrast ventriculography.
Only the subgroup of five patients with severely impaired myocardial performance in Grossman's study (mean ejection fraction 24%), however, had a significantly higher value of V0, and this tendency was observed in the five patients in our study with an ejection fraction <36% (see Fig. 5 ). In addition, there were no normal subjects in Grossman's study, and those with normal ejection fractions had evidence of systolic volume overload (mean end-systolic volume was 51 mum2). Thus, it appears that V0 is not a sensitive index of myocardial performance in normal subjects and seems to be consistently raised only when both myocardial contractility is severely impaired and end-systolic volume is greatly enlarged.
The P/V ratio was of similar sensitivity to the ejection fraction in the detection of patients with left ventricular dysfunction caused by coronary artery disease, at rest and after each of the pharmacological interventions. One interesting difference was in the response to atropine in the normal subjects. The P/V ratio rose in all 12 subjects after atropine, whereas the ejection fraction only rose in four subjects. Since it is now established that an increase in heart rate per se constitutes a positive inotropic stimulus in man,21 these findings further support the increased sensitivity of the systolic P/V relation over the ejection fraction as an index of the prevailing inotropic state.
Increasing afterload on the left ventricle with phenylephrine led to a similar dose-dependent decline in both the P/V ratio and the ejection fraction-both more pronounced in the normal subjects than in the patients with coronary artery disease. It was assumed for the purposes of this study that Isometric and dynamic exercise generally increase the sensitivity of indices of myocardial performance for differentiating normal subjects from those with left ventricular dysfunction caused by coronary artery disease. This has proved to be the case with studies using the systolic pressure/volume relation.78 The response of both blood pressure and heart rate to any given level of exercise, however, may vary widely, both within and between subjects. We felt that pharmacological afterload stress, with control of the systolic blood pressure and heart rate, might further increase the sensitivity of this index for detecting minor degrees of left ventricular dysfunction caused by coronary artery disease. The fact that no such increase in sensitivity was seen may be because our study did not incorporate a positive inotropic stimulus such as that which occu'rs with exercise, and a study using isoprenaline under similar conditions is in progress.
One potential limitation on the interpretation of our findings is the younger mean age of the normal subjects. We are not aware of any studies that show an effect of age per se on ejection phase indices of myocardial contractility. Aortic impedance may increase with age and it is thus possible that this would further depress the ejection fraction and the P/V ratio in the coronary disease group. 22 In conclusion, this study has evaluated the clinical utility of the peak systolic pressure end-systolic volume relation in normal subjects and patients with coronary artery disease. While neither the P/V ratio nor the P/V slope appeared to be significantly better than the ejection fraction in the detection of left ventricular dysfunction resulting from coronary artery disease, the P/V ratio may more closely reflect the prevailing inotropic state of the left ventricle. Unlike both the P/V ratio and the ejection fraction, the P/V slope is independent of afterload and may therefore have special utility in the evaluation of cardiovascular drug effects in man. 
